SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION

Código QR

SYSTEMIC ANTIBODY AND CELLULAR IMMUNE RESPONSES IN INFLUENZA INFECTION AND POSTSVACCINATION

Abstract. Post-infection immunity represents an immunogenicity standard for antiviral vaccines, including those against influenza. To estimate the immunogenic properties of vaccine preparations, it is necessary to compare the quantitative and qualitative parameters of immune responses to the vaccine...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	S. A. Donina, A. N. Naikhin, G. D. Petukhova, I. B. Barantseva, T. V. Chirkova, Е. P. Grigor’eva, А. R. Rekstin, L. G. Rudenko
Formato:	article
Lenguaje:	RU
Publicado:	SPb RAACI 2014
Materias:	systemic immune responses influenza vaccination Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/63a2ae7c42e244b8a35ab0f4a8b9a66c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

LOCAL ANTIBODY AND CELLULAR IMMUNE RESPONSES TO INFLUENZA INFECTION AND VACCINATION
por: G. D. Petukhova, et al.
Publicado: (2014)

CROSSREACTIVE ANTIBODIES AND MEMORY T CELLS TO HUMAN AND ZOONOTIC INFLUENZA A VIRUSES IN VOLUNTEERS
por: I. V. Losev, et al.
Publicado: (2015)

OMOLOGICAL AND HETEROLOGICAL ANTIBODY AND T CELL IMMUNE RESPONSES TO LIVE ATTENUATED INFLUENZA VACCINE A (H5N2) AND A (H7N3)
por: A. N. Naykhin, et al.
Publicado: (2015)

Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
por: I. Losev, et al.
Publicado: (2019)

AVIDITY EVALUATION OF LOCAL IgA ANTIBODIES IN PERSONS IMMUNIZED WITH LIVE INFLUENZA VACCINE
por: S. A. Donina, et al.
Publicado: (2014)

Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies
por: Rachael Keating, et al.
Publicado: (2020)

HETEROSUBTYPIC IMMUNE RESPONSE AND CROSS-PROTECTION AGAINST A HIGHLY PATHOGENIC A (H5N1) INFLUENZA VIRUS IN MICE IMMUNIZED WITH COLD-ADAPTED A/LENINGRAD/134/17/57 (H2N2) INFLUENZA VIRUS
por: A. R. Rekstin, et al.
Publicado: (2014)

APPLICATION OF METHOD BASED ON IN VITRO ANTIBODY QUANTIFICATION IN PBMC SUPERNATANT SAMPLES FOR IMMUNOGENICITY EVALUATION OF A (H5N1) AND A (H5N2) POTENTIALLY PANDEMIC INFLUENZA VACCINES IN CLINICAL TRIALS
por: I. V. Losev, et al.
Publicado: (2016)

Induction of cross-reactive antibodies in mice immunized with conserved influenza A virus neuraminidase-derived linear B-cell epitopes
por: I. A. Sychev, et al.
Publicado: (2021)

INDUCTION OF LONG-TERM T AND B CELL MEMORY IMMUNITY TO INFLUENZA A VIRUS (H5N1) IN PERSONS VACCINATED WITH LIVE INFLUENZA A VACCINE (H5N2)
por: I. V. Losev, et al.
Publicado: (2017)

EVALUATION OF T CELL IMMUNOLOGICAL MEMORY BY MEANS OF CD45+ EXPRESSION IN HUMANS VACCINATED WITH LIVE REASSORTANT INFLUENZA VACCINE
por: A. N. Naikhin, et al.
Publicado: (2014)

IMMUNOGENICITY OF ADJUVANT INFLUENZA VACCINE FOR PREGNANT WOMEN
por: M. P. Kostinov, et al.
Publicado: (2017)

Influenza Vaccination Programs for Healthcare Personnel: Organizational Issues and Beyond
por: Helena C. Maltezou, et al.
Publicado: (2021)

Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
por: Laura Sánchez-de Prada, et al.
Publicado: (2021)

Features of immune response against influenza infection in animals vaccinated with recombinant cross-protective vaccine
por: L. M. Tsybalova, et al.
Publicado: (2019)

Patients’ Perception and Knowledge about Influenza and Pneumococcal Vaccination during the COVID-19 Pandemic: An Online Survey in Patients at Risk of Infections
por: Paul Loubet, et al.
Publicado: (2021)

Enhancement of the Local CD8<sup>+</sup> T-Cellular Immune Response to <i>Mycobacterium tuberculosis</i> in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens
por: Kirill Vasilyev, et al.
Publicado: (2021)

Factors Associated with Attitudes towards Seasonal Influenza Vaccination in Poland: A Nationwide Cross-Sectional Survey in 2020
por: Piotr Samel-Kowalik, et al.
Publicado: (2021)

Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells
por: Michael S. Piepenbrink, et al.
Publicado: (2019)

Influenza: Profilaxis mediante la inmunización activa
por: FICA C.,ALBERTO
Publicado: (2001)

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
por: Kizzmekia S. Corbett, et al.
Publicado: (2019)

Fcγ Receptors Contribute to the Antiviral Properties of Influenza Virus Neuraminidase-Specific Antibodies
por: E. R. Job, et al.
Publicado: (2019)

Granzyme B: A Double-Edged Sword in the Response to Influenza Infection in Vaccinated Older Adults
por: Chris P. Verschoor, et al.
Publicado: (2021)

Nasal spray live attenuated influenza vaccine: the first experience in Italy in children and adolescents during the 2020–21 season
por: Chiara Gasparini, et al.
Publicado: (2021)

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
por: Florian Krammer, et al.
Publicado: (2018)

CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
por: I. B. Esmagambetov, et al.
Publicado: (2016)

Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells
por: Li-Meng Yan, et al.
Publicado: (2020)

Serological Responses to Influenza Vaccination during Pregnancy
por: Ana Vazquez-Pagan, et al.
Publicado: (2021)

Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans
por: Daniel Stadlbauer, et al.
Publicado: (2017)

Prescripción de la vacuna anti influenza por médicos institucionales y estudiantes de especialidades médicas en un hospital docente
por: FICA C,ALBERTO, et al.
Publicado: (2001)

Intranasal immunization with a recombinant protein based on the M2e peptide and second subunit of influenza A viral hemagglutinin fragment induces a cross-protective humoral and Tcell response in mice
por: M. A Shuklina, et al.
Publicado: (2020)

Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs
por: Meagan McMahon, et al.
Publicado: (2019)

Generation of DelNS1 Influenza Viruses: a Strategy for Optimizing Live Attenuated Influenza Vaccines
por: Pui Wang, et al.
Publicado: (2019)

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence
por: Lang PO, et al.
Publicado: (2012)

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults
por: Philip Meade, et al.
Publicado: (2020)

Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections
por: Ivette A. Nuñez, et al.
Publicado: (2021)

The Usage of Influenza Vaccine to Prevent Seasonal Influenza during Pandemic COVID-19
por: Yelvi Levani, et al.
Publicado: (2021)

Public Interest in Distribution and Determinants of Influenza and Pneumonia Vaccination during the COVID-19 Pandemic: An Infodemiology and Cross-Sectional Study from China
por: Liubing Gong, et al.
Publicado: (2021)

<named-content content-type="genus-species">Staphylococcus aureus</named-content> Lipase 1 Enhances Influenza A Virus Replication
por: Mariya I. Goncheva, et al.
Publicado: (2020)

Protective Efficacy of an Orf Virus-Vector Encoding the Hemagglutinin and the Nucleoprotein of Influenza A Virus in Swine
por: Lok R. Joshi, et al.
Publicado: (2021)